219 related articles for article (PubMed ID: 18042220)
21. Evolution of artificial cells using nanobiotechnology of hemoglobin based RBC blood substitute as an example.
Chang TM
Artif Cells Blood Substit Immobil Biotechnol; 2006; 34(6):551-66. PubMed ID: 17090428
[TBL] [Abstract][Full Text] [Related]
22. Static structures and dynamics of hemoglobin vesicle (HBV) developed as a transfusion alternative.
Sato T; Sakai H; Sou K; Medebach M; Glatter O; Tsuchida E
J Phys Chem B; 2009 Jun; 113(24):8418-28. PubMed ID: 19469497
[TBL] [Abstract][Full Text] [Related]
23. Histopathological changes of rat brain after direct injection of Hb-vesicles (artificial oxygen carriers) and neurological impact in an intracerebral hemorrhage model.
Sakai H; Okamoto M; Ikeda E; Horinouchi H; Kobayashi K; Tsuchida E
J Biomed Mater Res A; 2009 Sep; 90(4):1107-19. PubMed ID: 18671266
[TBL] [Abstract][Full Text] [Related]
24. Circulation kinetics and organ distribution of Hb-vesicles developed as a red blood cell substitute.
Sou K; Klipper R; Goins B; Tsuchida E; Phillips WT
J Pharmacol Exp Ther; 2005 Feb; 312(2):702-9. PubMed ID: 15459236
[TBL] [Abstract][Full Text] [Related]
25. Gas bioengineering using hemoglobin-vesicles for versatile clinical applications.
Sakai H; Takeoka S; Kobayashi K
Curr Pharm Des; 2011; 17(22):2352-9. PubMed ID: 21736544
[TBL] [Abstract][Full Text] [Related]
26. Neohemocytes.
Hunt CA; Burnette RR
Prog Clin Biol Res; 1983; 122():59-69. PubMed ID: 6878382
[TBL] [Abstract][Full Text] [Related]
27. Artificial oxygen carriers as red blood cell substitutes: a selected review and current status.
Kim HW; Greenburg AG
Artif Organs; 2004 Sep; 28(9):813-28. PubMed ID: 15320945
[TBL] [Abstract][Full Text] [Related]
28. [Recent progress and trend in the development of artificial blood].
Tsuchida E
Nihon Rinsho; 1994 Sep; 52(9):2483-91. PubMed ID: 7967100
[TBL] [Abstract][Full Text] [Related]
29. Overview of Potential Clinical Applications of Hemoglobin Vesicles (HbV) as Artificial Red Cells, Evidenced by Preclinical Studies of the Academic Research Consortium.
Sakai H
J Funct Biomater; 2017 Mar; 8(1):. PubMed ID: 28294960
[TBL] [Abstract][Full Text] [Related]
30. An overview of unresolved inherent problems associated with red cell transfusion and potential use of artificial oxygen carriers and ECO-RBC: current status/future trends.
Seghatchian J; de Sousa G
Transfus Apher Sci; 2007 Dec; 37(3):251-9. PubMed ID: 18042438
[TBL] [Abstract][Full Text] [Related]
31. Rheological properties of hemoglobin vesicles (artificial oxygen carriers) suspended in a series of plasma-substitute solutions.
Sakai H; Sato A; Takeoka S; Tsuchida E
Langmuir; 2007 Jul; 23(15):8121-8. PubMed ID: 17567054
[TBL] [Abstract][Full Text] [Related]
32. The influence of oxidative stress on microviscosity of hemoglobin-containing liposomes.
Górnicki A
Gen Physiol Biophys; 2003 Mar; 22(1):121-7. PubMed ID: 12870707
[TBL] [Abstract][Full Text] [Related]
33. Pretreatment of serum containing hemoglobin vesicles (oxygen carriers) to prevent their interference in laboratory tests.
Sakai H; Tomiyama K; Masada Y; Takeoka S; Horinouchi H; Kobayashi K; Tsuchida E
Clin Chem Lab Med; 2003 Feb; 41(2):222-31. PubMed ID: 12667011
[TBL] [Abstract][Full Text] [Related]
34. Intrinsic toxicity of hemoglobin: how to counteract it.
Simoni J; Simoni G; Moeller JF
Artif Organs; 2009 Feb; 33(2):100-9. PubMed ID: 19178453
[TBL] [Abstract][Full Text] [Related]
35. Synthetic carriers of oxygen.
Dellacherie E; Labrude P; Vigneron C; Riess JG
Crit Rev Ther Drug Carrier Syst; 1987; 3(1):41-94. PubMed ID: 3542244
[TBL] [Abstract][Full Text] [Related]
36. Swine hemoglobin as a potential source of artificial oxygen carriers, hemoglobin-vesicles.
Sakai H; Ng K; Li B; Sugimura N
Artif Cells Nanomed Biotechnol; 2013 Feb; 41(1):37-41. PubMed ID: 22992176
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Hemoglobin-based oxygen carriers to stored human red blood cells.
Eastman AL; Minei JP
Crit Care Clin; 2009 Apr; 25(2):303-10, Table of Contents. PubMed ID: 19341910
[TBL] [Abstract][Full Text] [Related]
38. Recent and prominent examples of nano- and microarchitectures as hemoglobin-based oxygen carriers.
Jansman MMT; Hosta-Rigau L
Adv Colloid Interface Sci; 2018 Oct; 260():65-84. PubMed ID: 30177214
[TBL] [Abstract][Full Text] [Related]
39. Complete deoxygenation from a hemoglobin solution by an electrochemical method and heat treatment for virus inactivation.
Huang Y; Takeoka S; Sakai H; Abe H; Hirayama J; Ikebuchi K; Ikeda H; Tsuchida E
Biotechnol Prog; 2002; 18(1):101-7. PubMed ID: 11822907
[TBL] [Abstract][Full Text] [Related]
40. [Progress in the red cell substitutes (artificial red cells)].
Tsuchida E
Rinsho Ketsueki; 1994 May; 35(5):439-45. PubMed ID: 8028190
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
